{"id":163357,"date":"2024-07-30T06:30:34","date_gmt":"2024-07-30T10:30:34","guid":{"rendered":"https:\/\/44.250.171.167\/?p=163357"},"modified":"2024-07-30T06:30:36","modified_gmt":"2024-07-30T10:30:36","slug":"cipla-ltd-q1fy25-18-rise-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/cipla-ltd-q1fy25-18-rise-in-profits\/","title":{"rendered":"Cipla Ltd Q1FY25; 18% rise in Profits"},"content":{"rendered":"\n<p>Cipla is engaged in the Business of Pharmaceuticals.<\/p>\n\n\n\n<p style=\"font-size:24px\"><strong>Financial Results:<\/strong><\/p>\n\n\n\n<p>Cipla Ltd reported Revenues for Q1FY25 of \u20b96,694.00 Crores up from \u20b96,329.00 Crore year on year, a rise of 5.77%.<\/p>\n\n\n\n<p>Total Expenses for Q1FY25 of \u20b95,243.00 Crores up from \u20b95,090.00 Crores year on year, a rise of 3.01%.<\/p>\n\n\n\n<p>Consolidated Net Profit of \u20b91,175.00 Crores up 17.74% from \u20b9998.00 Crores in the same quarter of the previous year.<\/p>\n\n\n\n<p>The Earnings per Share is \u20b914.58, up 18.25% from \u20b912.33 in the same quarter of the previous year.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p>*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.<\/p>\n\n\n\n<p>*The presented data is automatically generated. It may occasionally generate incorrect information.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cipla is engaged in the Business of Pharmaceuticals. Financial Results: Cipla Ltd reported Revenues for Q1FY25 of \u20b96,694.00 Crores up from \u20b96,329.00 Crore year on year, a rise of 5.77%. Total Expenses for Q1FY25 of \u20b95,243.00 Crores up from \u20b95,090.00 Crores year on year, a rise of 3.01%. Consolidated Net Profit of \u20b91,175.00 Crores up [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":163355,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[10162],"class_list":["post-163357","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","tag-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-190.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":165582,"url":"https:\/\/alphastreet.com\/india\/cipla-ltd-q2fy25-13-rise-in-profits\/","url_meta":{"origin":163357,"position":0},"title":"Cipla Ltd Q2FY25; 13% rise in Profits","author":"Divyansh_Kasana","date":"November 13, 2024","format":false,"excerpt":"Cipla is engaged in the Business of Pharmaceuticals.(Source : 202003 Annual Report Page No:157) Financial Results: Cipla Ltd reported Revenues for Q2FY25 of \u20b97,051.00 Crores up from \u20b96,678.00 Crore year on year, a rise of 5.59%. Total Expenses for Q2FY25 of \u20b95,452.00 Crores up from \u20b95,260.00 Crores year on year,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/DT-1.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/DT-1.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/DT-1.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/DT-1.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/DT-1.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/DT-1.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":167458,"url":"https:\/\/alphastreet.com\/india\/cipla-ltd-q3fy25-47-rise-in-profits\/","url_meta":{"origin":163357,"position":1},"title":"Cipla Ltd Q3FY25; 47% rise in Profits","author":"Divyansh_Kasana","date":"March 19, 2025","format":false,"excerpt":"Cipla is engaged in the Business of Pharmaceuticals.(Source : 202003 Annual Report Page No:157) Financial Results: Cipla Ltd reported Revenues for Q3FY25 of \u20b97,073.00 Crores up from \u20b96,604.00 Crore year on year, a rise of 7.1%. Total Expenses for Q3FY25 of \u20b95,379.00 Crores up from \u20b95,119.00 Crores year on year,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/U-10.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/U-10.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/U-10.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/U-10.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/U-10.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/U-10.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":168941,"url":"https:\/\/alphastreet.com\/india\/cipla-ltd-q4fy25-30-rise-in-profits-2\/","url_meta":{"origin":163357,"position":2},"title":"Cipla Ltd Q4FY25; 30% rise in Profits","author":"Divyansh_Kasana","date":"June 30, 2025","format":false,"excerpt":"Cipla is engaged in the Business of Pharmaceuticals.(Source : 202003 Annual Report Page No:157) Financial Results: Cipla Ltd reported Revenues for Q4FY25 of \u20b96,730.00 Crores up from \u20b96,163.00 Crore year on year, a rise of 9.2%. Total Expenses for Q4FY25 of \u20b95,515.00 Crores up from \u20b95,153.00 Crores year on year,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-19.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-19.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-19.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-19.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-19.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-19.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":150055,"url":"https:\/\/alphastreet.com\/india\/cipla-ltd-q1fy24-41-rise-in-profits\/","url_meta":{"origin":163357,"position":3},"title":"Cipla Ltd Q1FY24; 41% rise in Profits.","author":"Divyansh_Kasana","date":"July 26, 2023","format":false,"excerpt":"Cipla is engaged in the Business of Pharmaceuticals. Financial Results: Cipla Ltd reported Revenues for Q1FY24 of \u20b96,329.00 Crores up from \u20b95,375.00 Crore year on year, a rise of 17.75%. Total Expenses for Q1FY24 of \u20b95,090.00 Crores up from \u20b94,504.00 Crores year on year, a rise of 13.01%. Consolidated Net\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-269.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-269.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-269.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-269.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-269.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-269.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":161981,"url":"https:\/\/alphastreet.com\/india\/cipla-ltd-q4fy24-79-rise-in-profits\/","url_meta":{"origin":163357,"position":4},"title":"Cipla Ltd Q4FY24; 79% rise in Profits","author":"Divyansh_Kasana","date":"June 6, 2024","format":false,"excerpt":"Cipla is engaged in the Business of Pharmaceuticals. Financial Results: Cipla Ltd reported Revenues for Q4FY24 of \u20b96,163.00 Crores up from \u20b95,739.00 Crore year on year, a rise of 7.39%. Total Expenses for Q4FY24 of \u20b95,153.00 Crores up from \u20b94,946.00 Crores year on year, a rise of 4.19%. Consolidated Net\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-73.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-73.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-73.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-73.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-73.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-73.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":155523,"url":"https:\/\/alphastreet.com\/india\/cipla-ltd-q2fy24-45-rise-in-profits\/","url_meta":{"origin":163357,"position":5},"title":"Cipla Ltd Q2FY24; 45% rise in Profits","author":"Divyansh_Kasana","date":"October 31, 2023","format":false,"excerpt":"Cipla is engaged in the Business of Pharmaceuticals.(Source : 202003 Annual Report Page No:157) Financial Results: Cipla Ltd reported Revenues for Q2FY24 of \u20b96,678.00 Crores up from \u20b95,829.00 Crore year on year, a rise of 14.57%. Total Expenses for Q2FY24 of \u20b95,260.00 Crores up from \u20b94,851.00 Crores year on year,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/image-183.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/image-183.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/image-183.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/image-183.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/image-183.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/image-183.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/163357","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=163357"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/163357\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/163355"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=163357"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=163357"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=163357"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}